En vivo
BioWorldMoney raised by biopharmaBioWorldBiopharma money raised: Jan. 1-June 4, 2026BioWorldBioWorld and Nasdaq stock indicesEndpoints NewsHouse committee directs FDA to speed up IND sign-off processFierceBiotechExecutive Interviews at Fierce Biotech Week 2026BioWorldBiopharma money raised by month in 2026 (US$M)BioPharma DiveStudy data convince Lundbeck to push new migraine drug forwardBioPharma DiveGeneric drugmakers gain key victory in ‘skinny label’ patent caseEndpoints NewsInnovent declares Phase 3 success for ADC that attracted huge Takeda dealFierceBiotechAffibody gets izokibep ‘back on track’ while seeking ‘new home’ after drug’s Acelyrin rejectionClinical OMICsInfluenza Drugs Could Prevent Cognitive Decline in Chronic Viral InfectionsBioWorldRoche develops PCR test to detect the Ebola Bundibugyo virus
FierceBiotech 21 abr 2026

Gilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure

Gilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure

Original
Contenido no disponible. Consulta la fuente original.